Published in J Cell Mol Med on May 15, 2009
The role of tissue engineering in articular cartilage repair and regeneration. Crit Rev Biomed Eng (2009) 1.23
Comprehensive profiling of cartilage extracellular matrix formation and maturation using sequential extraction and label-free quantitative proteomics. Mol Cell Proteomics (2010) 1.18
Clinically translatable cell tracking and quantification by MRI in cartilage repair using superparamagnetic iron oxides. PLoS One (2011) 1.07
International Cartilage Repair Society (ICRS) Recommended Guidelines for Histological Endpoints for Cartilage Repair Studies in Animal Models and Clinical Trials. Cartilage (2011) 1.01
Advances in the Use of Stem Cells in Veterinary Medicine: From Basic Research to Clinical Practice. Scientifica (Cairo) (2016) 0.98
Barriers to the clinical translation of orthopedic tissue engineering. Tissue Eng Part B Rev (2011) 0.98
Human developmental chondrogenesis as a basis for engineering chondrocytes from pluripotent stem cells. Stem Cell Reports (2013) 0.96
Controlled delivery of mesenchymal stem cells and growth factors using a nanofiber scaffold for tendon repair. Acta Biomater (2013) 0.93
Regenerative medicine: then and now--an update of recent history into future possibilities. J Cell Mol Med (2010) 0.90
Magnetic resonance imaging probes for labeling of chondrocyte cells. J Mater Sci Mater Med (2011) 0.89
Toll-like receptors in human chondrocytes and osteoarthritic cartilage. Acta Orthop (2013) 0.88
MACI - a new era? Sports Med Arthrosc Rehabil Ther Technol (2011) 0.84
An osteochondral culture model to study mechanisms involved in articular cartilage repair. Tissue Eng Part C Methods (2011) 0.84
Intrinsic repair of full-thickness articular cartilage defects in the axolotl salamander. Osteoarthritis Cartilage (2010) 0.83
Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model. Eur Cell Mater (2013) 0.83
Mesenchymal stem-cell potential in cartilage repair: an update. J Cell Mol Med (2014) 0.80
Regeneration of articular cartilage of the knee. Rheumatol Int (2012) 0.80
Chondroitin Sulfate Immobilized on a Biomimetic Scaffold Modulates Inflammation While Driving Chondrogenesis. Stem Cells Transl Med (2016) 0.78
Thrombin promotes matrix metalloproteinase-13 expression through the PKCδ c-Src/EGFR/PI3K/Akt/AP-1 signaling pathway in human chondrocytes. Mediators Inflamm (2013) 0.78
Preclinical good laboratory practice-compliant safety study to evaluate biodistribution and tumorigenicity of a cartilage advanced therapy medicinal product (ATMP). J Transl Med (2015) 0.78
Periodic heat shock accelerated the chondrogenic differentiation of human mesenchymal stem cells in pellet culture. PLoS One (2014) 0.78
An ex vivo continuous passive motion model in a porcine knee for assessing primary stability of cell-free collagen gel plugs. BMC Musculoskelet Disord (2010) 0.78
Effect of microfracture and autologous-conditioned plasma application in the focal full-thickness chondral defect of the knee: an experimental study on rabbits. J Orthop Surg Res (2015) 0.77
Role of Cartilage Forming Cells in Regenerative Medicine for Cartilage Repair. Orthop Res Rev (2010) 0.77
Cartilage repair in osteoarthritic patients: utopia or real opportunity? F1000 Med Rep (2009) 0.76
Harnessing the Versatility of Bacterial Collagen to Improve the Chondrogenic Potential of Porous Collagen Scaffolds. Adv Healthc Mater (2016) 0.76
Recent highlights on bone stem cells: a report from Bone Stem Cells 2009, and not only…. J Cell Mol Med (2010) 0.76
Cartilage repair in the degenerative ageing knee. Acta Orthop (2016) 0.75
Neuroleukin/Autocrine Motility Factor Receptor Pathway Promotes Proliferation of Articular Chondrocytes through Activation of AKT and Smad2/3. Sci Rep (2015) 0.75
Epiphyseal Chondroprogenitors Provide a Stable Cell Source for Cartilage Cell Therapy. Cell Med (2012) 0.75
Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration. Stem Cell Res Ther (2017) 0.75
Microfluidics‑based optimization of neuroleukin‑mediated regulation of articular chondrocyte proliferation. Mol Med Rep (2015) 0.75
Fibrin Scaffolds Designing in order to Human Adipose-derived Mesenchymal Stem Cells Differentiation to Chondrocytes in the Presence of TGF-β3. Int J Stem Cells (2015) 0.75
Treatment with embryonic stem-like cells into osteochondral defects in sheep femoral condyles. BMC Vet Res (2014) 0.75
Co-culture of chondrons and mesenchymal stromal cells reduces the loss of collagen VI and improves extracellular matrix production. Histochem Cell Biol (2017) 0.75
Infrapatellar Fat Pad Stem Cells: From Developmental Biology to Cell Therapy. Stem Cells Int (2017) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Generation of germline-competent induced pluripotent stem cells. Nature (2007) 32.77
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58
Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 20.65
Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med (1994) 14.46
Mesenchymal stem cells as trophic mediators. J Cell Biochem (2006) 9.38
The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1987) 9.24
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol (2007) 9.04
In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res (1998) 8.24
Understanding, improving and using green fluorescent proteins. Trends Biochem Sci (1995) 7.51
Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell (1982) 6.61
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J (2006) 5.93
Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One (2008) 5.91
Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng (1998) 4.54
A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med (2004) 4.37
Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum (2005) 4.25
Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum (2006) 4.16
A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br (2003) 4.16
Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med (2008) 3.89
A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am (2007) 3.73
Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am (1994) 3.62
Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature (1977) 3.46
Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective, comparative trial. J Bone Joint Surg Am (2003) 3.39
Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum (2003) 3.39
The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am (1998) 3.32
Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage (2006) 3.10
Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am (1993) 2.98
The response of articular cartilage to mechanical injury. J Bone Joint Surg Am (1982) 2.92
Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage (2002) 2.78
Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol (2008) 2.41
FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol (2005) 2.31
Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem (1997) 2.15
Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br (2005) 2.13
A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. Dev Biol (2008) 2.09
The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum (2004) 2.08
The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs (2002) 1.95
In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection. Joint Bone Spine (2008) 1.91
Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum (2003) 1.90
Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum (2004) 1.89
Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem (2001) 1.86
Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI)--5-year follow-up. Knee (2006) 1.83
Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells (2005) 1.80
Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol (2007) 1.79
Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician (2008) 1.79
Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br (2002) 1.76
Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum (2001) 1.71
Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci U S A (2008) 1.70
Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng (2006) 1.67
Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif (2007) 1.67
Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant (2004) 1.65
Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage (2006) 1.64
OP-1/BMP-7 in cartilage repair. Int Orthop (2007) 1.59
Is microfracture of chondral defects in the knee associated with different results in patients aged 40 years or younger? Arthroscopy (2006) 1.56
Immunochemical and mechanical characterization of cartilage subtypes in rabbit. J Histochem Cytochem (2002) 1.56
The structural architecture of adult mammalian articular cartilage evolves by a synchronized process of tissue resorption and neoformation during postnatal development. Osteoarthritis Cartilage (2006) 1.56
Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res (2006) 1.55
Autologous chondrocyte implantation. Am J Knee Surg (2000) 1.55
Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys (1988) 1.55
Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage (2005) 1.53
Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. J Orthop Res (2006) 1.50
The repair of experimentally produced defects in rabbit articular cartilage by autologous chondrocyte transplantation. J Orthop Res (1989) 1.48
BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem (2001) 1.47
In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem (2006) 1.47
The repair of large osteochondral defects. An experimental study in horses. Clin Orthop Relat Res (1972) 1.46
Articular cartilage engineering with autologous chondrocyte transplantation. A review of recent developments. J Bone Joint Surg Am (2003) 1.44
Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev (2007) 1.43
Experimental model for cartilage tissue engineering to regenerate the zonal organization of articular cartilage. Osteoarthritis Cartilage (2003) 1.37
Chondrogenic differentiation of human embryonic stem cells: the effect of the micro-environment. Tissue Eng (2006) 1.36
Tissue engineering of stratified articular cartilage from chondrocyte subpopulations. Osteoarthritis Cartilage (2003) 1.36
Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum (2004) 1.34
Nonmyeloablative conditioning is sufficient to allow engraftment of EGFP-expressing bone marrow and subsequent acceptance of EGFP-transgenic skin grafts in mice. Blood (2003) 1.33
Repair of articular cartilage defects treated by microfracture and a three-dimensional collagen matrix. Biomaterials (2005) 1.32
Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun (2008) 1.31
Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes. J Orthop Res (2000) 1.30
Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthritis Cartilage (2002) 1.29
Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res (2005) 1.29
Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage (2004) 1.28
Three-dimensional tissue engineering of hyaline cartilage: comparison of adult nasal and articular chondrocytes. Tissue Eng (2002) 1.26
Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders. Cytokine Growth Factor Rev (2002) 1.24
Differential effects of BMP-2 and TGF-beta1 on chondrogenic differentiation of adipose derived stem cells. Cell Prolif (2007) 1.22
Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Joint Surg Am (2000) 1.21
Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J Cell Physiol (2006) 1.20
Comparative evaluation of autologous chondrocyte implantation and mosaicplasty: a multicentered randomized clinical trial. Clin J Sport Med (2005) 1.20
Repair of large chondral defects of the knee with autologous chondrocyte implantation in patients 45 years or older. Am J Sports Med (2008) 1.20
Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng (2002) 1.20
Cartilage tissue engineering for laryngotracheal reconstruction: comparison of chondrocytes from three anatomic locations in the rabbit. Tissue Eng (2007) 1.19
Chitosan-glycerol phosphate/blood implants increase cell recruitment, transient vascularization and subchondral bone remodeling in drilled cartilage defects. Osteoarthritis Cartilage (2006) 1.18
Imaging of knee osteoarthritis: data beyond the beauty. Curr Opin Rheumatol (2007) 1.17
Derivation of chondrogenically-committed cells from human embryonic cells for cartilage tissue regeneration. PLoS One (2008) 1.16
FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-beta signaling. Cytotechnology (2007) 1.15
Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model. J Orthop Res (2005) 1.15
Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model. Mol Ther (2000) 1.14
Differential behavior of auricular and articular chondrocytes in hyaluronic acid hydrogels. Tissue Eng Part A (2008) 1.14
Comparison of different chondrocytes for use in tissue engineering of cartilage model structures. Tissue Eng (2006) 1.13
Hyaluronan-based polymers in the treatment of osteochondral defects. J Orthop Res (2000) 1.12
Mesenchymal stem cells as trophic mediators. J Cell Biochem (2006) 9.38
Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med (2008) 3.89
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol (2004) 3.23
Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy (2002) 2.78
NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis. J Clin Invest (2013) 2.48
Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum (2007) 2.45
Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med (2010) 2.43
Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med (2002) 2.36
Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med (2009) 2.32
Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years. J Bone Joint Surg Am (2003) 2.24
Histological assessment of cartilage repair: a report by the Histology Endpoint Committee of the International Cartilage Repair Society (ICRS). J Bone Joint Surg Am (2003) 2.24
The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol (2010) 2.21
A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum (2010) 2.02
Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum (2006) 2.01
Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol (2003) 1.99
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med (2006) 1.97
Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J (2003) 1.80
Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease. J Rheumatol (2003) 1.77
Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis (2010) 1.75
Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res (2003) 1.75
Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol (2006) 1.75
Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest (2005) 1.73
Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum (2003) 1.67
Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet (2008) 1.63
Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis. PLoS One (2012) 1.63
Use of polymerase chain reaction to diagnose tuberculous arthritis from joint tissues and synovial fluid. Arch Pathol Lab Med (2004) 1.63
Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum (2007) 1.61
Immunochemical and mechanical characterization of cartilage subtypes in rabbit. J Histochem Cytochem (2002) 1.56
Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol (2006) 1.56
PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels. Endocrinology (2011) 1.54
Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial. Arthritis Rheum (2011) 1.54
Revision total knee arthroplasty: 1990 through 2002. A review of the Finnish arthroplasty registry. J Bone Joint Surg Am (2006) 1.52
Tight regulation of wingless-type signaling in the articular cartilage - subchondral bone biomechanical unit: transcriptomics in Frzb-knockout mice. Arthritis Res Ther (2012) 1.52
Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med (2009) 1.50
Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells. Stem Cells (2012) 1.49
Outcome of prosthesis exchange for infected knee arthroplasty: the effect of treatment approach. Acta Orthop (2009) 1.48
Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants. J Rheumatol (2005) 1.46
Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol (2009) 1.46
Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 1.46
Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am J Hum Genet (2008) 1.45
Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther (2009) 1.42
Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs. Clin Rheumatol (2013) 1.42
Corneal innervation and morphology in primary Sjögren's syndrome. Invest Ophthalmol Vis Sci (2003) 1.41
Incidence of prosthetic joint infections after primary knee arthroplasty. J Arthroplasty (2008) 1.37
Mesenchymal stem cells and cardiac repair. J Cell Mol Med (2008) 1.37
The subchondral bone in articular cartilage repair: current problems in the surgical management. Knee Surg Sports Traumatol Arthrosc (2010) 1.36
Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome. Exp Eye Res (2008) 1.36
Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum (2004) 1.34
Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol (2010) 1.34
Younger age increases the risk of early prosthesis failure following primary total knee replacement for osteoarthritis. A follow-up study of 32,019 total knee replacements in the Finnish Arthroplasty Register. Acta Orthop (2010) 1.34
Low rate of infected knee replacements in a nationwide series--is it an underestimate? Acta Orthop (2009) 1.32
Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am J Sports Med (2011) 1.31
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. Stem Cells Int (2013) 1.30
Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther (2010) 1.28
Prevention of deep infection in joint replacement surgery. Acta Orthop (2010) 1.28
Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci U S A (2012) 1.28
Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL. Arthritis Rheum (2009) 1.27
Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part I: from three-dimensional cell growth to biomimetics of in vivo development. Tissue Eng Part B Rev (2009) 1.26
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One (2008) 1.26
In-vivo generation of bone via endochondral ossification by in-vitro chondrogenic priming of adult human and rat mesenchymal stem cells. BMC Musculoskelet Disord (2011) 1.26
Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty. Innate Immun (2012) 1.24
Proliferation and differentiation potential of chondrocytes from osteoarthritic patients. Arthritis Res Ther (2005) 1.23
Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol (2009) 1.23
Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis. Arthritis Res Ther (2012) 1.20
Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng (2002) 1.20
Cartilage tissue engineering for laryngotracheal reconstruction: comparison of chondrocytes from three anatomic locations in the rabbit. Tissue Eng (2007) 1.19
Alternative materials to improve total hip replacement tribology. Acta Orthop Scand (2003) 1.18
Macrophages-Key cells in the response to wear debris from joint replacements. J Biomed Mater Res A (2013) 1.18
Cartilage tissue engineering for degenerative joint disease. Adv Drug Deliv Rev (2006) 1.18
Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Biochem Biophys Res Commun (2013) 1.18
Bioabsorbable miniplating versus metallic fixation for metacarpal fractures. Clin Orthop Relat Res (2003) 1.17
Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J Rheumatol (2002) 1.16
Donor site morbidity after articular cartilage repair procedures: a review. Acta Orthop Belg (2010) 1.14
Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography. PLoS One (2012) 1.14
Amyloidosis-recent developments. Semin Arthritis Rheum (2008) 1.14
Biological aspects of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc (2011) 1.13
Effects of MRI contrast agents on the stem cell phenotype. Cell Transplant (2010) 1.13
One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating. PLoS One (2012) 1.12
Total hip replacement in patients eighty years of age and older. J Bone Joint Surg Am (2008) 1.12
Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev (2005) 1.11
Postnatal establishment of allelic Gαs silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Gαs disruption. J Bone Miner Res (2014) 1.10
Repair of osteochondral defect with tissue-engineered two-phase composite material of injectable calcium phosphate and hyaluronan sponge. Tissue Eng (2002) 1.09
Correlation between magnetic resonance imaging and clinical outcomes after knee cartilage repair: letter to the editor. Am J Sports Med (2013) 1.08
Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis. Arthritis Rheum (2006) 1.07
Bcl11a is required for neuronal morphogenesis and sensory circuit formation in dorsal spinal cord development. Development (2012) 1.07
GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann Rheum Dis (2010) 1.07
The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials (2011) 1.07
B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives. Autoimmun Rev (2011) 1.07
Targeting mesenchymal stem cells to activated endothelial cells. Biomaterials (2009) 1.06
A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum (2008) 1.06
Autologous chondrocyte implantation versus microfracture for knee cartilage injury: a prospective randomized trial, with 2-year follow-up. Knee Surg Sports Traumatol Arthrosc (2009) 1.06
The Noggin null mouse phenotype is strain dependent and haploinsufficiency leads to skeletal defects. Dev Dyn (2006) 1.06
Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. J Clin Endocrinol Metab (2009) 1.06
In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J Orthop Res (2009) 1.05
Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology (2013) 1.05
Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen. Biochemistry (2003) 1.04
Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells in vivo. Exp Cell Res (2003) 1.04
Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol (2013) 1.04
Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med (2011) 1.03